Daewon Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Daewon Pharmaceutical Stock Forecast and Price Target
If Daewon Pharmaceutical's stock price reached the average yearlong target of ₩21000.00 given by two well-known analysts in recent months, there would be a potential upside of approximately 40.37% from its last closing price in May, 2024. This potential increase is based on a high estimate of ₩22000.00 and a low estimate of ₩20000.00. Even if you are not interested in A003220 stock, you should still be aware of its competitors.
40.37% Upside
Daewon Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Daewon Pharmaceutical's Price has decreased from ₩2949.30 to ₩0.00 – a 100.00% drop. The next year looks promising for Daewon Pharmaceutical, with analysts predicting Fair Value of ₩12.98k – an increase of 100.00%. Over the next seven years, experts anticipate that Daewon Pharmaceutical's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A128940 Stock Forecast | Hanmi Pharm. | Outperform |
18
|
₩316.50k | Buy/Sell | ₩382.71k | 31.12% |
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩104.60k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩211.50k | Buy/Sell | ₩201.75k | 3.55% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩36.10k | Buy/Sell | ₩44.67k | 24.65% |
Daewon Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Daewon Pharmaceutical's Revenue has grown, increasing from ₩308.50B to ₩478.88B – a growth of 55.23%. The next year looks promising for Daewon Pharmaceutical, with analysts predicting Revenue of ₩527.15B – an increase of 10.08%. Over the next seven years, experts anticipate that Daewon Pharmaceutical's Revenue will grow at a rate of 3.87%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩104.30k | Buy/Sell | ₩124.29k | 43.82% |
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩111.90k | Buy/Sell | ₩156.10k | 38.52% |
.jpg)
Daewon Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Daewon Pharmaceutical's Dividend per Share has grown by 118.75%, from ₩160.00 to ₩350.00. 4 analysts predict Daewon Pharmaceutical's Dividend per Share will decrease by 13.57% in the next year, reaching ₩302.50. By 2030, professionals predict that Daewon Pharmaceutical's Dividend per Share will decrease by 16.53%, to ₩292.14.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
| A003090 Stock Forecast | Daewoong | Outperform |
14
|
₩18.82k | Buy/Sell | ₩38.00k | 32.84% |
| A003850 Stock Forecast | Boryung | Buy |
17
|
₩11.15k | Buy/Sell | ₩13.50k | 43.50% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩16.48k | Buy/Sell | ₩20.00k | 45.63% |
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩30.95k | Buy/Sell | ₩40.62k | 35.70% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
Daewon Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Daewon Pharmaceutical's EBITDA has grown by 57.04%, rising from ₩39.65B to ₩62.27B. In the following year, the 4 analysts surveyed believe that Daewon Pharmaceutical's EBITDA will decrease by 2.00%, reaching ₩61.03B. According to professionals, by 2030, Daewon Pharmaceutical's EBITDA will have decreased by 6.44%, falling down to ₩58.26B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩67.60k | Buy/Sell | ₩74.50k | 20.56% |
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
Daewon Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Daewon Pharmaceutical's EBIT has grown by 78.93%, rising from ₩23.98B to ₩42.90B. The next year, 4 experts forecast that Daewon Pharmaceutical's EBIT will decrease by 0.71%, reaching ₩42.60B. In 2030, professionals predict that Daewon Pharmaceutical's EBIT will decrease by 6.27%, reaching ₩40.21B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩34.10k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.36k | Buy/Sell | ₩17.66k | -100.00% |
Daewon Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Daewon Pharmaceutical's EPS has decreased from ₩339.00 to ₩0.00 – a 100.00% drop. The next year looks promising for Daewon Pharmaceutical, with analysts predicting EPS of ₩1492.00 – an increase of 100.00%. Over the next seven years, experts anticipate that Daewon Pharmaceutical's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A249420 Stock Forecast | Ildong Pharmaceutical | Outperform |
12
|
₩15.53k | Buy/Sell | ₩23.00k | 60.98% |
| A053030 Stock Forecast | BINEX | - |
16
|
₩14.01k | Buy/Sell | ₩18.00k | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
Site Navigation
.jpg)